Bill Cassidy actually said...
One of the benefits of the oral antivirals Paxlovid and molnupiravir is that they have much broader activity against SARS-CoV-2 and its variants.
Context
Cassidy discusses the effectiveness of antiviral treatments against COVID-19 variants.
01/10/2022